Literature DB >> 10767546

p53 splice acceptor site mutation and increased HsRAD51 protein expression in Bloom's syndrome GM1492 fibroblasts.

K P Magnusson1, M Sandström, M Ståhlberg, M Larsson, J Flygare, D Hellgren, K G Wiman, S Ljungquist.   

Abstract

GM1492 human diploid skin fibroblasts derived from a patient with Bloom's syndrome (BS), lack detectable p53 mRNA and protein as shown by Northern and Western blotting, and express an increased RecA-like activity. Here we demonstrate that the p53 gene is grossly intact in GM1492 cells according to Southern blotting. DNA sequencing did not reveal any mutations in the promoter region of p53. A highly sensitive RT-PCR produced a p53 cDNA fragment that was shorter than expected. DNA sequence analysis of p53 cDNA showed that exon 6 was missing, explaining the shorter PCR product. Furthermore, sequencing of genomic DNA revealed a base substitution at the nucleotide preceding the AG splice acceptor site of intron 5. The omission of exon 6 creates a frameshift at the junction of exons 5 and 7, and a premature stop codon in exon 7. The aberrant transcript is predicted to encode a truncated p53 protein containing 189 amino acid residues. Moreover, Western blotting demonstrated elevated HsRAD51 protein levels in GM1492 cells. The lack of sufficient levels of wild-type p53 and increased levels of HsRad51 protein may contribute to the elevated RecA-like activity in the GM1492 fibroblasts.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10767546     DOI: 10.1016/s0378-1119(00)00068-8

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  5 in total

1.  Discovery of TP53 splice variants in two novel papillary urothelial cancer cell lines.

Authors:  Annemarie Koch; Jiri Hatina; Harald Rieder; Hans-Helge Seifert; Wolfgang Huckenbeck; Frank Jankowiak; Andrea R Florl; Robert Stoehr; Wolfgang A Schulz
Journal:  Cell Oncol (Dordr)       Date:  2012-06-06       Impact factor: 6.730

Review 2.  Organizing principles of mammalian nonsense-mediated mRNA decay.

Authors:  Maximilian Wei-Lin Popp; Lynne E Maquat
Journal:  Annu Rev Genet       Date:  2013       Impact factor: 16.830

3.  Ionizing radiation, inflammation, and their interactions in colon carcinogenesis in Mlh1-deficient mice.

Authors:  Takamitsu Morioka; Tomoko Miyoshi-Imamura; Benjamin J Blyth; Mutsumi Kaminishi; Toshiaki Kokubo; Mayumi Nishimura; Seiji Kito; Yutaka Tokairin; Shusuke Tani; Kimiko Murakami-Murofushi; Naoki Yoshimi; Yoshiya Shimada; Shizuko Kakinuma
Journal:  Cancer Sci       Date:  2015-02-12       Impact factor: 6.716

4.  Modulation of Early Mitotic Inhibitor 1 (EMI1) depletion on the sensitivity of PARP inhibitors in BRCA1 mutated triple-negative breast cancer cells.

Authors:  Dina Moustafa; Maha R Abd Elwahed; Hanaa H Elsaid; Jeffrey D Parvin
Journal:  PLoS One       Date:  2021-01-07       Impact factor: 3.240

Review 5.  The consequence of oncomorphic TP53 mutations in ovarian cancer.

Authors:  Pavla Brachova; Kristina W Thiel; Kimberly K Leslie
Journal:  Int J Mol Sci       Date:  2013-09-23       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.